Related Experiment Video

Updated: Aug 20, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Can diabetes be cured by therapeutic cloning?

Ahmi Ben-Yehudah1, Selma F Witchel, Sang Hwan Hyun

  • 1Pittsburgh Development Center, Magee Womens Research Institute, 204 Craft Avenue, Pittsburg, PA 15213, USA.

Pediatric Diabetes
|December 17, 2004
PubMed

Insights

Novel stem cell therapies show promise for diabetes mellitus (DM) treatment by generating insulin-producing beta-cells. Research is ongoing to optimize protocols and address challenges like autoimmune destruction for effective DM management.

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Diabetes Mellitus Research

Background:

  • Diabetes mellitus (DM) incidence is rising globally, necessitating innovative therapeutic approaches.
  • Stem cells present a potential source for glucose-responsive, insulin-secreting beta-cells.
  • Current challenges include developing consistent protocols for beta-cell enrichment and determining optimal stem cell sources (embryonic, fetal, adult).

Purpose of the Study:

  • To review innovative treatment strategies for diabetes mellitus.
  • To evaluate the potential of stem cell-based therapies for DM.
  • To consider the advantages and challenges associated with stem cell applications in DM treatment.

Main Methods:

  • Literature review of current research on stem cell therapy for DM.
  • Analysis of different stem cell types (embryonic, fetal, adult) for therapeutic potential.
  • Discussion of techniques like somatic cell nuclear transfer and their implications.

Main Results:

  • Stem cells offer a renewable source for insulin-producing beta-cells.
  • Somatic cell nuclear transfer may circumvent some transplantation issues.
  • Autoimmune destruction remains a significant challenge, particularly in type 1 DM.

Conclusions:

  • Stem cell therapy holds significant promise for treating diabetes mellitus.
  • Further research is required to refine protocols and overcome existing challenges.
  • Addressing autoimmune destruction is critical for the long-term success of beta-cell replacement therapies.

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...